Others and we have shown that CCL20/CCR6 auto-signaling occurs in prostatic cancerous cells and that tumor CCR6 expression correlates with disease aggressiveness [7], [26], thus marking intra-tumoral CCL20/CCR6 interactions as a pro-carcinogenic axis. Here, CCL20 is linked to neoplasm.